<span item_type="fundamental" item_id="34f96d035f67d892892306d129b37822" counter_id="ST/US/CCRN" env="prod"></span><span item_type="announcement" item_id="645843700328764673" env="prod"></span><p>Revenue: As of FY2026 Q1, the actual value is USD 241.06 M, beating the estimate of USD 236.84 M.</p><p>EPS: As of FY2026 Q1, the actual value is USD -0.14, missing the estimate of USD -0.048.</p><p>EBIT: As of FY2026 Q1, the actual value is USD -4.562 M.</p><p></p><h3>Consolidated Financial Performance</h3><h4>Revenue</h4><p>Cross Country Healthcare, Inc. reported revenue of $241,057 thousand for the first quarter ended March 31, 2026, representing an 18% decrease year-over-year and a 2% increase sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Gross Profit Margin</h4><p>The gross profit margin was 19.7%, a decrease of 30 basis points year-over-year and 60 basis points sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Net Loss Attributable to Common Stockholders</h4><p>Net loss attributable to common stockholders was - $4,266 thousand, compared to a net loss of - $490 thousand in the prior year and - $82,929 thousand in the prior quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Adjusted EBITDA</h4><p>Adjusted EBITDA was $3,853 thousand, or 1.6% of revenue, marking a 55% decrease year-over-year and a 5% decrease sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Adjusted EBITDA Margin</h4><p>The Adjusted EBITDA Margin was 1.6%, a decrease of 130 basis points year-over-year and 10 basis points sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h3>Segment Revenue</h3><h4>Nurse and Allied Staffing Revenue</h4><p>Nurse and Allied Staffing revenue was $201,444 thousand, a 17% decrease year-over-year and a 4% increase sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Physician Staffing Revenue</h4><p>Physician Staffing revenue was $39,613 thousand, a 23% decrease year-over-year and a 7% decrease sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Cross Country Community Care Revenue Growth</h4><p>Cross Country Community Care experienced 16% year-over-year growth <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h3>Segment Contribution Income</h3><h4>Nurse and Allied Staffing Contribution Income</h4><p>Nurse and Allied Staffing contribution income was $12,728 thousand, a 26% decrease year-over-year and a 1% increase sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Physician Staffing Contribution Income</h4><p>Physician Staffing contribution income was $2,787 thousand, a 31% decrease year-over-year and a 16% decrease sequentially <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h3>Operational Metrics</h3><h4>Nurse and Allied Staffing FTEs</h4><p>Nurse and Allied Staffing FTEs totaled 6,363, compared to 7,411 in the prior year and 6,318 in the prior quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Average Nurse and Allied Staffing Revenue per FTE per Day</h4><p>Average Nurse and Allied Staffing revenue per FTE per day was $351, compared to $360 in the prior year and $333 in the prior quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Physician Staffing Days Filled</h4><p>Physician Staffing days filled were 17,688, compared to 22,692 in the prior year and 18,599 in the prior quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Physician Staffing Revenue per Day Filled</h4><p>Physician Staffing revenue per day filled was $2,240, compared to $2,253 in the prior year and $2,286 in the prior quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>New Agreements and Technology</h4><p>Cross Country Healthcare, Inc. signed 4 new MSP/VMS agreements and licensed Intellify®, its workforce intelligence platform, to a top ten healthcare staffing provider <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Share Repurchases</h4><p>The company repurchased 0.7 million shares of common stock for $5.8 million during the quarter, at an average price of $8.86 per share <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h3>Cash Flow and Balance Sheet Highlights</h3><h4>Net Cash Provided by Operating Activities</h4><p>Net cash provided by operating activities was $4,767 thousand for the three months ended March 31, 2026, compared to $5,681 thousand in the prior year and $18,239 thousand in the prior quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Cash and Cash Equivalents</h4><p>Cross Country Healthcare, Inc. closed the quarter with $105,584 thousand in cash and cash equivalents <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Debt</h4><p>There was no debt outstanding at quarter-end <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Share Repurchase Authorization</h4><p>$28.1 million remained for share repurchase as of March 31, 2026 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h4>Borrowing Base Availability</h4><p>There was $109.3 million available under the ABL, with $91.0 million available net of letters of credit <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p><h3>Outlook</h3><p>Cross Country Healthcare, Inc. is awaiting the closing of a pending transaction with Knox Lane in the third quarter <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>. The company’s focus remains on disciplined execution and advancing technology initiatives <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>. Due to the proposed merger, the company canceled its earnings conference call for the first quarter 2026 financial results <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1141103/000162828026032217/ccrn20260331prexhibit991.htm"></span>.</p>

Cross Country Healthcare | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 241.06 M